Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: SOP for System Suitability Criteria for HPLC and GC Methods – V 2.0

Posted on By

Analytical Method Development: SOP for System Suitability Criteria for HPLC and GC Methods – V 2.0

Standard Operating Procedure for Establishing System Suitability Criteria in HPLC and GC Analytical Methods


Department Analytical Method Development
SOP No. SOP/AMD/370/2025
Supersedes SOP/AMD/370/2022
Page No. Page 1 of 14
Issue Date 01/06/2025
Effective Date 04/06/2025
Review Date 01/06/2027

1. Purpose

This Standard Operating Procedure (SOP) defines the procedure for establishing and evaluating system suitability criteria for chromatographic methods using High-Performance Liquid Chromatography (HPLC) and Gas Chromatography (GC)

in the Analytical Method Development (AMD) laboratory. System suitability tests (SST) confirm that the system is operating correctly before and during analytical runs to ensure method reliability and data integrity.

2. Scope

This procedure applies to all HPLC and GC methods being developed, validated, transferred, or used for routine quality control within the AMD function for raw materials, APIs, and finished products.

See also  Analytical Method Development: SOP for Selection of Analytical Techniques - V 2.0

3. Responsibilities

  • Analyst: Prepares system suitability standards, initiates runs, calculates system suitability parameters.
  • AMD Scientist: Defines acceptance criteria based on method development studies and literature references.
  • QA: Reviews system suitability trends and approves SST criteria during validation and transfer.

4. Accountability

The Head of Analytical Method Development is accountable for ensuring compliance with SST protocols in accordance with ICH, USP, and regulatory guidelines.

5. Procedure

5.1 Identification of SST Parameters

Select system suitability parameters relevant to the method type and critical performance attributes:

  • Retention Time (RT)
  • Theoretical Plates (N)
  • Resolution (Rs)
  • Tailoring Factor (T)
  • Repeatability (%RSD) of peak area from multiple injections

5.2 Preparation of SST Standard

  1. Prepare standard solution at defined concentration according to the analytical method.
  2. Filter and sonicate the solution if required.
  3. Ensure that SST standard contains analyte and impurities where applicable.

5.3 Instrumental Setup and Injections

  1. Use validated or qualified instruments (HPLC/GC) for all SST evaluations.
  2. Inject 5–6 replicates of SST standard solution to evaluate repeatability and other criteria.
  3. Ensure column equilibrium and consistent baseline before starting injections.
See also  Analytical Method Development: SOP for TGA Method for Moisture and Volatile Content - V 2.0

5.4 Acceptance Criteria

Parameter Typical Acceptance Range
% RSD (Peak Area) Not more than 2.0%
Resolution (Rs) between main peak and impurity Not less than 2.0
Theoretical Plates (N) As per method development; typically > 2000
Tailoring Factor 1.0–2.0

5.5 Troubleshooting

  1. If SST criteria fail, do not analyze test samples.
  2. Investigate root cause (e.g., column condition, mobile phase, injection volume, temperature).
  3. Document any deviation and recondition the system or replace column if necessary.

5.6 Documentation

  1. Record SST results in the System Suitability Record Sheet (Annexure-1).
  2. Attach chromatograms of all injections used for SST calculation.
  3. Include a justification section in validation or routine reports referring to SST results.

6. Abbreviations

  • SST: System Suitability Test
  • RT: Retention Time
  • N: Theoretical Plates
  • Rs: Resolution
  • RSD: Relative Standard Deviation

7. Documents

  1. Annexure-1: System Suitability Record Sheet
  2. Annexure-2: SST Deviation Log
  3. Instrument Logbook
See also  Analytical Method Development: Laser Diffraction Method Optimization - V 2.0

8. References

  • ICH Q2(R1): Validation of Analytical Procedures
  • USP General Chapter <621> Chromatography
  • 21 CFR Part 211 – cGMP for Finished Pharmaceuticals
  • Internal SOPs on HPLC/GC Qualification

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name Anil Jha Pooja Mahadik Dr. Shravan Kumar
Designation Senior Analyst QA Reviewer Head – AMD
Department Analytical Method Development Quality Assurance Analytical Method Development

11. Annexures

Annexure-1: System Suitability Record Sheet

Injection No. Peak Area RT (min) Resolution Tailing Factor Plates (N)
1 2501 5.65 2.5 1.15 3400
2 2503 5.64 2.6 1.14 3420
3 2498 5.63 2.5 1.13 3390

Annexure-2: SST Deviation Log

Date Instrument ID Deviation Observed Action Taken Remarks
31/05/2025 HPLC-007 RSD above 2.5% Reconditioning of column Criteria met post re-run

Revision History

Revision Date Revision No. Details Reason Approved By
01/06/2025 2.0 Expanded procedure for troubleshooting and tabular criteria Annual SOP Review Dr. Shravan Kumar
05/06/2022 1.0 First Release New SOP QA Head
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Analytical Method Development: SOP for Accuracy Assessment Using Recovery Study – V 2.0
Next Post: Analytical Method Development: SOP for Calculating and Interpreting Resolution in Chromatographic Methods – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version